Product image of Ziihera (Zanidatamab) supplied by GNH India

Ziihera

Active Ingredient:
Zanidatamab
Origin:
EU

Ziihera (Zanidatamab)

Ziihera (zanidatamab) is an intravenous therapy designed for targeted cancer treatment. This overview covers its therapeutic role, administration, and safety considerations for healthcare contexts. Explore how zanidatamab supports specific oncology needs.

Manufacturer / TM Owner

Jazz Pharmaceuticals Ireland Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zanidatamab is used in oncology to target HER2-expressing tumors, providing a therapeutic option for certain cancer types. It is prescribed when HER2 overexpression is confirmed, supporting treatment plans in metastatic or advanced settings. Patients and caregivers often ask, 'what is zanidatamab used for' to understand its role in care.

Side Effects

  • As an intravenous therapy, zanidatamab works systemically to target cancer cells expressing HER2 proteins. Common effects may include infusion-related reactions, which are typically managed under medical supervision. Individual responses vary based on treatment protocols and patient health.

Precautions & Warnings

  • Zanidatamab requires administration by healthcare professionals in a controlled setting due to its intravenous route. Patients should disclose full medical history, including allergies or prior reactions to infusions. Monitoring during and after administration helps manage potential reactions.

Avoid Interactions

  • Zanidatamab may interact with other HER2-targeted therapies or systemic cancer treatments. Caution is advised when combining with medications affecting immune response or infusion reactions. Always inform healthcare providers about all medications and supplements before starting zanidatamab.

Frequently Asked Questions

Zanidatamab is used to treat HER2-expressing cancers, such as certain metastatic or advanced tumors.

It is given as an intravenous infusion in a healthcare setting by trained professionals.

Infusion-related reactions are commonly reported; these are typically managed during treatment.

Combination therapy depends on individual treatment plans and should be discussed with a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Zanidatamab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT